Skip navigation
Real-Time Quotes
Get Free Real-Time Quotes Direct From the NYSE and the NASDAQ!
Company: Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. : [MLNM  Loading...      ()   ]
Generic drug giant Teva Pharmaceuticals bought rival Barr for $7 billion, and some analysts say this could spark a big wave of consolidation...
A look at the consolidation trends in the generic drug sector, with Shlomo Yanai, Teva Pharmaceuticals CEO
Inside the $7.46B deal, with Bruce Downey, Barr Pharmaceuticals chairman/CEO
Teva's $7B deal could be just the tip of the consolidation iceberg, with CNBC's Mike Huckman
Teva's $7B deal could be just the tip of the consolidation iceberg, with CNBC's Mike Huckman
Peter Stock, president & CIO of Stock Investment Management Inc
Novartis beat its earnings forecasts Thursday, posting a 17% rise in net profit for the second quarter. Nick Turner from Mirabaud Securities...
Novartis reported a 17% increase in second-quarter profit Thursday, helped by cost-cutting efforts. Edith Thouin from of ABN Amro Private Ba...
Abbott Labs beats the street, with Miles White, Abbott Labs chairman/CEO and CNBC's Mike Huckman
A look at the pharmaceutical company's earnings and performance of its cancer drug, with CNBC's Mike Huckman
Final thoughts, with Jimmy Wales, Wikia Inc.
Top media and tech moguls have the economy on their minds, with Jimmy Wales, Wikia Inc chairman/CEO and Andrew Ross Sorkin, NY Times reporte...
Ranbaxy will probably accept Daiichi Sankyo's buyout offer, predicts Aadil Ebrahim, investment manager at Bowen Capital Management. He revie...
A bright spot in the beaten down pharma sector, with CNBC's Mike Huckman
Germany's Fresenius plans to buy America's group APP Pharmaceuticals for $3.7 billion. Ulf Schneider, CEO of Fresenius, spoke to CNBC about ...
An update on the sector, with CNBC's Mike Huckman
Posts |  COMPANY : Millennium
10 Apr 2008
Following are the day’s biggest winners and losers... Read More
10 Apr 2008
This morning there's a plethora of stuff to blog about: the Takeda-Millennium deal, more commentary about Merck and Schering-Plough and the extent of the Vytorin/Zetia fallout, Genentech's biotech bellweather earnings after the closing bell today, just to name a few... Read More
19 Mar 2008
Posted By:Lightning Round
Cramer makes the call on viewers' favorite stocks.... Read More
7 Jan 2008
Here's our Fast Money Final Trade... Read More
News |  COMPANY : Millennium
Thursday, 10 Apr 2008
Source: Reuters
Friday, 28 Mar 2008
Source: CNBC.com
HOME  |  NEWS  |  MARKETS  |  EARNINGS  |  INVESTING  |  VIDEO  |  CNBC TV  |  CNBC PLUS  |  CNBC HD+
About CNBC   |   Site Map   |   Privacy Policy   |   Terms of Service   |   Advertise   |   Help   |   Feedback   |   Video Reprints
  Data is a real-time snapshot   *Data is delayed at least 15 minutes

Global Business and Financial News, Stock Quotes, and Market Data and Analysis